Status:
RECRUITING
Assessment of the Impact of the Return Home of Premature Newborns Less Than 2 Kilos Morbidity/Mortality
Lead Sponsor:
Hôpital NOVO
Conditions:
Premature Birth
Eligibility:
All Genders
1-11 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the impact of discharge from hospital with a weight of less than 2 kilos. To do this, the investigator will look at the short-term and long-term outcome of newbor...
Detailed Description
Prematurity in itself, whether simple or associated with intrauterine growth retardation, continues to be a real public health problem. In addition to gestational age at birth, the presence of co-morb...
Eligibility Criteria
Inclusion
- Premature newborn baby (born at less than 37 days' gestation)
- Newborn baby with IUGR (Intra-Uterine Growth Retardation)
- Newborn baby hospitalised in the neonatology department of the NOVO hospital - Pontoise site
- Patient born between 01/01/2012 and 31/12/2024.
- Newborn who has left the neonatology department or the Kangaroo Unit to return home weighing less than 2 kg.
- Newborn beneficiary of a social security scheme or entitled person.
Exclusion
- Newborn transferred to another hospital before discharge.
- Refusal by one of the parents.
- Parent does not speak or understand French.
Key Trial Info
Start Date :
February 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06224764
Start Date
February 21 2024
End Date
November 1 2025
Last Update
January 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Resuscitation and neonatal medicine department - Hôpital NOVO - Pontoise site
Pontoise, France, 95300